Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

NCT01462630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Adult Angiosarcoma
Recurrent Adult Soft Tissue Sarcoma
Stage III Adult Soft Tissue Sarcoma
Stage IV Adult Soft Tissue Sarcoma

Interventions

DRUG: pazopanib hydrochloride
OTHER: laboratory biomarker analysis
PROCEDURE: positron emission tomography
PROCEDURE: computed tomography
RADIATION: fludeoxyglucose F 18

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]